Dose modifications

Top banner braf

Dose modifications for BRAFTOVI when combined with cetuximab1



  • Please see the BRAFTOVI Summary of Product Characteristics for recommended dose modifications for adverse reactions when combined with cetuximab
  • For dose modification information for cetuximab, refer to the cetuximab Summary of Product Characteristics

Download the Therapy Management Guide for more information on dosing and adverse reactions

Download the file

Thank you for the interest you give to our publications. Before accessing to our document, please tell us more about you.

HealthCare Professionals​

This is an international website for BRAFTOVI dedicated to Healthcare professionals ​​

IMPORTANT: the information on this website is based on the European Summary of Product Characteristics. Prescribing Information and indication may vary per country. You must refer to your country prescribing information. Please be aware we do not take responsibility for accessing such information which may not comply with the regulation or usage in your country.

I certify that:

I am Healthcare Professional outside the US and I have read the information above​. 


This is an international website for BRAFTOVI dedicated to Healthcare professionals.

I am a patient outside the US​